Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic.

It is being held in lieu of the cancelled OHDSI European Symposium, which would have taken place in Oxford. Lead organiser Daniel Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS said: "Our organising committee was hit quite hard when we realised it would be necessary to cancel our long-awaited OHDSI European Symposium, but we quickly realised that our community could come together and make a difference in this global pandemic."

"We are using the time for a COVID-19 virtual study-a-thon that will catalyze a long journey of shared research ahead. Based on the early enthusiasm of our many registrants, I'm optimistic that we can make important progress on the journey and make a meaningful contribution to this international effort."

More than 290 people from 29 different countries have registered for the four-day online event. Alongside the Oxford team are researchers from Erasmus Medical Center, Columbia University, UCLA, Ajou University, Janssen Research and Development, and IQVIA with active participation across government, industry, and academia.

Read more on the Nuffield Department of Orthoapaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) website

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.